Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Biotechnology
Californian biopharma Olema Oncology has announced the closing of a $85 million Series C financing. 1 October 2020
Biotechnology
News of a collaborations with US pharma giant Pfizer sent the shares of Hong Kong-listed biotech CStone Pharmaceutical up as much as 39.6% to HK$12.98, the highest since early October last year. 30 September 2020
Pharmaceutical
Australia’s Starpharma today announced that it has raised A$45 million ($31.7 million) via a placement to domestic and international institutional and professional investors. 30 September 2020
Biotechnology
Newly-formed European venture capital firm Pureos Bioventures has raised $170 million for its first fund. 24 September 2020
Biotechnology
California, USA-based Nutcracker Therapeutics, a company developing and producing mRNA therapeutics, today announced not only a financing deal but also a new senior executive. 23 September 2020
Biotechnology
Coronavirus vaccine research in Australia has been supported by a grant from the Medical Research Future Fund (MRFF), worth over $2 million. 22 September 2020
Biotechnology
A major agreement between I-Mab and AbbVie will see the firms working together in oncology. 15 September 2020
Biotechnology
San Diego, USA-based Escient Pharmaceuticals, which is developing Mas-related G Protein-Coupled Receptor (MRGPR)-targeted drugs to address serious, underserved medical needs across a broad range of therapeutic indications, today announced the completion of a $77.5 million Series B financing. 15 September 2020
Biotechnology
A new precision medicine company, IcanoMAB, has been founded in Polling, Germany. 7 September 2020
Biotechnology
Chinese biotech InxMed (Nanjing) says that it has completed its Series A+ financing of 130 million renminbi (~$19 million), which was led by Ennovation Ventures and China Growth Capital and followed by InnoMed Capital and Grand Yangtze Capital 4 September 2020
Biotechnology
A new analysis from professional services firm BDO shows that demands for innovation have caused research and development (R&D) spend to outpace revenue growth from 2016 to 2019. 3 September 2020
Biotechnology
While the world’s attention has been rightfully focused on the hope of a breakthrough that will eradicate COVID-19, the private biotech sector has racked up record-breaking investments during the first half of 2020, writes Theresa Brady, director, events communications, on the Biotechnology Innovation Organization (BIO) website. 28 August 2020
Biotechnology
Privately-held US biopharma company Triumvira Immunologics has successfully completed a $55 million Series A financing round. 27 August 2020
Biotechnology
Sino-American outfit Connect Biopharma is $115 million better off after a Series C financing. 24 August 2020
Pharmaceutical
Alzheimer’s researchers are hoping for a breakthrough with a new targeted approach to preventing disease progression in certain people with the disease. 20 August 2020
Biotechnology
A $150 million investment in RNAi specialist Alnylam Pharmaceuticals has been completed, the first part of a major financing collaboration with Blackstone. 18 August 2020
Biotechnology
The European Investment Bank (EIB) and EryDel SpA have signed a contract to provide a loan of 30 million euros ($35.4 million) to the Italian biotech company EryDel. 10 August 2020
Pharmaceutical
A funding agreement between Biohaven Pharmaceutical and Royalty Pharma will provide up to $250 million in funding for Biohaven to advance its CGRP receptor antagonist program. 7 August 2020
Biotechnology
A new report from the advocacy organization the Alliance for Regenerative Medicine (ARM) paints an encouraging picture for the sector in the pace of the COVID-19 epidemic that is raging around the world, and which has also had a negative impact on many drugmakers as they reported second-quarter financials over the past couple of weeks. 7 August 2020
Biotechnology
Swiss biotech venture accelerator and incubator BaseLaunch has announced the fifth partner in BaseLaunch Phase II, the next stage in its company building activities. 6 August 2020
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze